|
Market Closed -
Nasdaq
02:30:00 14/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 7.860 USD | -7.53% |
|
-10.88% | -3.91% |
| 27/10 | Wedbush Adjusts Price Target on ORIC Pharmaceuticals to $14 From $17, Keeps Outperform Rating | MT |
| 23/10 | ORIC Pharmaceuticals, Inc. - Special Call |
| Market Cap | 81Cr 74Cr 68Cr 62Cr 116.11Cr 7.68TCr 120.2Cr 820.32Cr 325.27Cr 4.1TCr 305.74Cr 299.25Cr 13TCr | P/E 2026 * |
-5.17x | P/E 2027 * | -4.62x |
|---|---|---|---|---|---|
| Enterprise Value | 81Cr 74Cr 68Cr 62Cr 116.11Cr 7.68TCr 120.2Cr 820.32Cr 325.27Cr 4.1TCr 305.74Cr 299.25Cr 13TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
98.41% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ORIC | Delayed | |
CBOE
| ORIC | Real-time | |
|
Boerse Muenchen
| 4TZ | Real-time | |
|
Deutsche Boerse AG
| 4TZ | Delayed | |
|
Börse Stuttgart
| 4TZ | Delayed | |
|
Tradegate
| 4TZ | Real-time |
Last Transcript: ORIC Pharmaceuticals, Inc.
| 1 day | -7.53% | ||
| 1 week | -10.88% | ||
| Current month | -14.94% | ||
| 1 month | -30.50% | ||
| 3 months | -42.71% | ||
| 6 months | -8.60% | ||
| Current year | -3.91% |
| 1 week | 7.83 |  | 9.45 |
| 1 month | 7.83 | | 14.31 |
| Current year | 7.23 | | 14.68 |
| 1 year | 7.23 | | 14.68 |
| 3 years | 3.9 | | 16.65 |
| 5 years | 2.36 | | 17.99 |
| 10 years | 2.36 | | 40.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 47 | 07/05/2018 |
| Director of Finance/CFO | 52 | 01/09/2019 | |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 18/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Heyman
CHM | Chairman | 68 | 07/03/2018 |
Jacob Chacko
BRD | Director/Board Member | 47 | 07/05/2018 |
Mardi Dier
BRD | Director/Board Member | 62 | 01/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/10/26 | Exercice | Chief Financial Officer | 42,000 | 0.0405% | ||
| 01/10/26 | Exercice | Founder | 13,700 | 0.0132% | ||
| 28/09/26 | Exercice | Chief Financial Officer | 40,200 | 0.0388% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.53% | -10.88% | -35.52% | +28.22% | 81Cr | |
| -2.69% | -0.48% | +51.67% | +69.09% | 6.63TCr | |
| -0.92% | +7.67% | +14.26% | +90.92% | 6.06TCr | |
| 0.00% | +0.39% | +20.52% | +98.45% | 5.55TCr | |
| +0.14% | +2.35% | +13.08% | +109.47% | 4.76TCr | |
| -2.21% | -2.47% | +18.60% | +36.89% | 4.37TCr | |
| -2.30% | -10.40% | +167.61% | +776.79% | 3.73TCr | |
| +2.15% | +1.42% | +15.17% | +56.49% | 3.66TCr | |
| -2.32% | -2.24% | +75.52% | +52.70% | 3.22TCr | |
| +2.62% | +5.90% | -36.55% | +406.95% | 2.66TCr | |
| Average | -1.31% | -1.04% | +30.43% | +172.60% | 4TCr | |
| Weighted average by Cap. | -0.84% | +0.18% | +37.08% | +161.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -17Cr -15Cr -14Cr -13Cr -24Cr -1.57TCr -25Cr -167.3Cr -66Cr -836.89Cr -62Cr -61Cr -2.66TCr | -20Cr -18Cr -17Cr -15Cr -29Cr -1.9TCr -30Cr -202.77Cr -80Cr -1.01TCr -76Cr -74Cr -3.22TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $7.860 | -7.53% | 10,08,732 |
| 12/26/12 | $8.500 | -5.56% | 11,78,749 |
| 11/26/11 | $9.000 | +1.01% | 7,73,284 |
| 10/26/10 | $8.910 | -3.47% | 10,11,307 |
| 09/26/09 | $9.230 | +4.65% | 12,28,509 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ORIC Stock
Select your edition
All financial news and data tailored to specific country editions
